Skip to main content
Fig. 2 | Pilot and Feasibility Studies

Fig. 2

From: Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study

Fig. 2

Psychosocial and clinical severity scores among participants in group 2 by treatment response category. CGI-S scores (A), SSQ scores (B) and CORE-10 scores (C) were collected for all members of group 2 at baseline (N = 10). Four participants were classified as complete responders, three as partial responders and three as non-responders. Follow-up scores could not be collected for the three non-responders. In addition, one partial responder did not provide follow-up data for the SSQ and CORE 10 scores. Data are mean ± SD. Two-tailed t-tests were used to determine statistical differences

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784